BETHESDA, Md., Sept. 27, 2016 /PRNewswire/ -- WealthEngine (WE), the leading provider of predictive marketing, analytics and audience development services, is pleased to announce its collaboration with The Leukemia & Lymphoma Society (LLS), the world's largest voluntary health agency dedicated to fighting blood cancer. WealthEngine aims to help further LLS's goal of creating a world without blood cancer by improving their overall donor development strategy through valuable solutions, data, and analytics.
WealthEngine will bring its powerful wealth intelligence to LLS through a complete solution that includes FindWealth 8, WE Prospect, and WE Analyze – the world's first automated modeling and analytics tool for fundraising. Coupled with screening services, professional services, and training, LLS is enabled to achieve their fundraising and donor development strategies and targets.
WealthEngine will provide comprehensive wealth insight to LLS through the WE Salesforce Connector, a powerful integration with the Salesforce platform. Through this solution, LLS will benefit from greatly enriched profiles of both current and prospective donors right directly within their own Salesforce instance.
By working with WealthEngine, LLS will be able to:
- Realize an uplift in fundraising
- Analyze current donors to target more like their best
- Identify and segment potential donors
- Prioritize and inform donor engagement with ratings and scores
- Infuse Salesforce in real time with actionable donor data
"We are very excited to join with WealthEngine; they have a passion and dedication for helping nonprofits reach their fundraising goals to further their missions," said Claude Edkins, Senior Vice President and Chief Information Officer at LLS. "Using WealthEngine along with Salesforce will help us become much more data-driven and drive fundraising results. As a result, we have already increased our major gift thresholds."
"We are extremely proud to work with The Leukemia & Lymphoma Society and welcome them to the WealthEngine family," said Mark Logan, President and CEO at WealthEngine. "At WealthEngine we look to empower nonprofits and provide them with solutions to fulfill their missions, and that's what we're doing with LLS. We look forward to a long and successful relationship with them."
WealthEngine™, Inc. is the leading provider of predictive marketing analytics, audience development and wealth intelligence services to nonprofit organizations, financial services, and luxury brands. Named a Cool Vendor in Data-Driven Marketing by Gartner, marketers and fundraisers use WealthEngine's comprehensive insights to understand what drives consumer decisions and when best to engage them. Headquartered in Bethesda, MD, WealthEngine serves both the United States and the United Kingdom. For more information, please visit wealthengine.com.
About The Leukemia & Lymphoma Society
The Leukemia & Lymphoma Society® is the world's largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world, provides free information and support services, and is the voice for all blood cancer patients seeking access to quality, affordable, coordinated care.
Founded in 1949 and headquartered in Rye Brook, NY, LLS has chapters throughout the United States and Canada. To learn more, visit lls.org or contact the Information Resource Center at (800) 955-4572.